Перевести на Переведено сервисом «Яндекс.Перевод»

Regeneron Pharmaceuticals

Country
USA
Краткое название
Regeneron Pharmaceuticals
Headquarters
777 Old Saw Mill River Road
Members of the board
Leonard S. Schleifer, M.D., Ph.D. — Founder, President, and Chief Executive Officer
George D. Yancopoulos, M.D., Ph.D. — Founding Scientist, President, Regeneron Laboratories & Chief Scientific Officer
Murray A. Goldberg — Senior Vice President, Finance and Administration, Chief Financial Officer, Treasurer, and Assistant Secretary
Joseph J. LaRosa — Senior Vice President, General Counsel and Secretary
Peter Powchik, M.D. — Senior Vice President, Clinical Development
Neil Stahl, Ph.D. — Senior Vice President, Research and Development Sciences
Robert J. Terifay — Senior Vice President, Commercial
Daniel Van Plew — Senior Vice President and General Manager, Industrial Operations
and Product Supply
George D. Yancopoulos, M.D., Ph.D. — Founding Scientist, President, Regeneron Laboratories
& Chief Scientific Officer
Categories medicine
Cardiology, Oncology, Dermatology, Orthopedics, Ophthalmology, Rheumatology
Stage of the project
Production
Disease
Senile macular degeneration, Rheumatoid arthritis, Atopic dermatitis
Ticker
REGN
Current owners

P. Roy Vagelos, M.D.
Charles A. Baker
Michael S. Brown, M.D.
Alfred G. Gilman, M.D., Ph.D.
Joseph L. Goldstein, M.D.
Christine A. Poon
Arthur F. Ryan
Leonard S. Schleifer, M.D., Ph.D.
Eric M. Shooter, Ph.D.
George L. Sing
Marc Tessier-Lavigne, Ph.D.
George D. Yancopoulos, M.D., Ph.D.

Assets
52.8100
Technology
Devices, Technologies, Pharmaceuticals, Chemistry